LCI133
LCI133 is an innovative, highly potent, and selective multi-target kinase inhibitor effective at the nanomolar level. It targets CDK4/6/9 and AURKA/B with IC50 values of 4.7/10.2/4.1 nM and 2.8/10.6 nM, respectively. In MYCN-amplified neuroblastoma BE (2) -C cells, LCI133 induces S/G2 phase arrest and triggers significant apoptosis (apoptosis) . Moreover, LCI133 demonstrates substantial antitumor efficacy in BE (2) -C neuroblastoma xenograft models.
Product Specifications
CAS Number
3065284-87-6
Smiles
O=C1C=C (OC2=CC (=CC=C12) C=3C=CC (=CC3) NC=4N=CC=5C=C (C (=O) N (C) C) N (C5N4) C6CCCC6) N7CCOCC7
Molecular Formula
C33H34N6O4
Molecular Weight
578.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6299223-01 0.2 mL
FH, NT (FH, Fumarate hydratase, mitochondrial) (FITC)
Sign In for Pricing
View Details MBS6299223-02 5x 0.2 mL
FH, NT (FH, Fumarate hydratase, mitochondrial) (FITC)
Sign In for Pricing
View Details 
GTR15341541 1 Vial
Lentiviral human TSPAN8 shRNA (UAS) - Lentiviral human TSPAN8 shRNA (UAS) (100)
Sign In for Pricing
View Details 